UL1TR002378
Cooperative Agreement
Overview
Grant Description
Georgia Clinical & Translational Science Alliance (GACTSA)
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Atlanta,
Georgia
30322
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 06/30/22 to 07/31/27 and the total obligations have increased 914% from $8,161,473 to $82,761,797.
Emory University was awarded
Georgia Clinical & Translational Science Alliance (Georgia CTSA)
Cooperative Agreement UL1TR002378
worth $82,761,797
from National Center for Advancing Translational Sciences in September 2017 with work to be completed primarily in Atlanta Georgia United States.
The grant
has a duration of 9 years 10 months and
was awarded through assistance program 93.350 National Center for Advancing Translational Sciences.
The Cooperative Agreement was awarded through grant opportunity Clinical and Translational Science Award (U54 Clinical Trial Optional).
Status
(Ongoing)
Last Modified 8/20/25
Period of Performance
9/22/17
Start Date
7/31/27
End Date
Funding Split
$82.8M
Federal Obligation
$0.0
Non-Federal Obligation
$82.8M
Total Obligated
Activity Timeline
Transaction History
Modifications to UL1TR002378
Additional Detail
Award ID FAIN
UL1TR002378
SAI Number
UL1TR002378-973775122
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NR00 NIH National Center for Advancing Translational Sciences
Funding Office
75NR00 NIH National Center for Advancing Translational Sciences
Awardee UEI
S352L5PJLMP8
Awardee CAGE
2K291
Performance District
GA-05
Senators
Jon Ossoff
Raphael Warnock
Raphael Warnock
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Center for Advancing Translational Sciences, National Institutes of Health, Health and Human Services (075-0875) | Health research and training | Grants, subsidies, and contributions (41.0) | $79,362,724 | 100% |
Modified: 8/20/25